The Study on COgnition and Prognosis in the Elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomization
H Lithell, L Hansson, I Skoog, D Elmfeldt… - Journal of …, 2004 - journals.lww.com
H Lithell, L Hansson, I Skoog, D Elmfeldt, A Hofman, B Olofsson, P Trenkwalder, A Zanchetti…
Journal of hypertension, 2004•journals.lww.comObjective To assess clinical outcomes in the Study on COgnition and Prognosis in the
Elderly (SCOPE) in patients who did not receive add-on antihypertensive therapy after
randomization, ie in patients that best reflect the original intention of a placebo-controlled
trial. Design
Elderly (SCOPE) in patients who did not receive add-on antihypertensive therapy after
randomization, ie in patients that best reflect the original intention of a placebo-controlled
trial. Design
Abstract
Objective
To assess clinical outcomes in the Study on COgnition and Prognosis in the Elderly (SCOPE) in patients who did not receive add-on antihypertensive therapy after randomization, ie in patients that best reflect the original intention of a placebo-controlled trial.
Design
Lippincott Williams & Wilkins